With our hiPSC-derived glioma avatar system, we show that glioma-driven mutations, IDH1-mut and EGFRvIII, not only affect the AS landscapes and tumorigenicity, but also modulate the neural differentiation programs. Here, IDH1 is linked to central nervous system cancer.